Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer. Because docetaxel (Taxotere, RP 56976; Rhone-Poulenc Rorer, Antony, France) appeared to be active against breast cancer in phase I trials, we performed this phase II study. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of clinical oncology : official journal of the American Society of Clinical Oncology Pubmed

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.

Hudis, C A; Seidman, A D; Crown, J P; Balmaceda, C; Freilich, R; Gilewski, T A; Hakes, T B; Currie, V; Lebwohl, D E; Baselga, J; Raptis, G; Gollub, M; Robles, M; Bruno, R; Norton, L
Journal of clinical oncology : official journal of the American Society of Clinical Oncology , Volume 14 (1): 8 – Feb 23, 1996
Download PDF

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.


Abstract

Because docetaxel (Taxotere, RP 56976; Rhone-Poulenc Rorer, Antony, France) appeared to be active against breast cancer in phase I trials, we performed this phase II study.

Loading next page...
 
/lp/pubmed/phase-ii-and-pharmacologic-study-of-docetaxel-as-initial-chemotherapy-vmFdG08O0Z

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0732-183X
DOI
10.1200/JCO.1996.14.1.58
pmid
8558221

Abstract

Because docetaxel (Taxotere, RP 56976; Rhone-Poulenc Rorer, Antony, France) appeared to be active against breast cancer in phase I trials, we performed this phase II study.

Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology – Pubmed

Published: Feb 23, 1996

There are no references for this article.